Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update on durvalumab combined with neoadjuvant chemotherapy for resectable biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma [Phase 2]
A Phase 2 trial comparing adjuvant capecitabine to a gemcitabine plus cisplatin regimen in resected extrahepatic cholangiocarcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN) [Phase 2]
Phase 2 trial evaluating Envofolimab and Lenvatinib with Gemcitabine plus Cisplatin as first-line therapy for advanced biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer [Phase 2, Phase 3]
A study comparing SMT-NK Inj. plus pembrolizumab versus pembrolizumab alone in advanced biliary tract cancer is currently recruiting (Phase …
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Lenvatinib Combined With PD-1 Inhibitors as First-line Treatment for Unresectable/Advanced Biliary Tract Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating lenvatinib plus PD-1 inhibitors as first-line therapy for unresectable or advanced biliary tract cancer …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System. [Phase 2]
Phase 2 trial investigating tislelizumab plus lenvatinib and gemox for potentially resectable locally advanced malignant tumors of the bilia…
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors [Phase 2]
Phase 2 trial evaluating surufatinib combined with sintilimab and SCRT in various unresectable advanced solid tumors, including biliary trac…
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial of nal-IRI plus 5-FU/LV in metastatic biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies [Phase 2, Phase 3]
A trial update evaluating chemotherapy combined with immune checkpoint inhibitors in advanced biliary tract cancers across Phase 2 and Phase…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes [Phase 2]
Phase 2 trial evaluating pembrolizumab as second-line treatment for metastatic biliary tract cancer with integrated genomic analysis to iden…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study [Phase 2]
Phase II single-arm study evaluating pemetrexed plus erlotinib as salvage therapy in metastatic biliary tract cancer after failure of gemcit…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer [Phase 3]
Phase 3 trial comparing gemcitabine plus capecitabine versus capecitabine alone in curatively resected biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2 [Phase 2]
Phase 2 trial updating the combination of RC48-ADC with Envolizumab in locally advanced or metastatic biliary tract cancer with positive HER…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC [Phase 2, Phase 3]
Phase 2/3 trial evaluating gemcitabine plus cisplatin with or without bintrafusp alfa (M7824) in first-line biliary tract cancer; study term…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating the combination of radiotherapy with anti-PD-1 immunotherapy for unresectable biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for PT-112 combined with gemcitabine in advanced solid tumors (Phase 1/2) ongoing for biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC [Phase 1, Phase 2]
Open-label Phase I/II trial evaluating the PLENA regimen for unresectable pancreatic cancer or biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating allogeneic NK cells (SMT-NK) with pembrolizumab in advanced biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors [Phase 2]
Phase 2 trial evaluating tisleizumab with lenvatinib and XELOX in first-line treatment of advanced unresectable biliary tract tumors.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) [Phase 2]
Phase 2 trial of M7824 monotherapy in second-line biliary tract cancers (cholangiocarcinoma and gallbladder cancer) has completed with resul…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating MRG003 for EGFR-positive advanced/metastatic biliary tract cancer; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update for MRG002 in HER2-positive biliary tract cancer (advanced/metastatic, unresectable).
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: SHR-1210 in Combination With GEMOX in Patients With Advanced BTC [Phase 2]
Phase 2 trial of SHR-1210 combined with GEMOX in advanced biliary tract cancer and cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer [Phase 2]
A Phase 2 trial evaluating nivolumab with gemcitabine/cisplatin or with ipilimumab for advanced unresectable biliary tract cancer has comple…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer [Phase 2, Phase 3]
Clinical trial update for varlitinib in combination with capecitabine in biliary tract cancer (Phase 2/Phase 3) has completed with results p…